X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding X4 Pharmaceuticals, Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 56 | 51 | −5 |
| Shares | 16.3M | 16.1M | −286.2K (−1.8%) |
| Value | $28.6M | $15.5M | −$13.1M (−45.7%) |
New holders (5)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kestra Advisory Services, LLC | 33,000 | $32.0K | 0.00% |
| Ronald Blue Trust, Inc. | 8,520 | $15.0K | 0.00% |
| Private Advisor Group, LLC | 13,221 | $13.0K | 0.00% |
| Veritable, L.P. | 12,637 | $12.0K | 0.00% |
| Cutler Group LP | 1,019 | $0 | 0.00% |
Sold out (10)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ensign Peak Advisors, Inc | 176,530 | $309.0K |
| Kennedy Capital Management, Inc. | 113,848 | $199.0K |
| Jane Street Group, LLC | 36,847 | $64.0K |
| Susquehanna International Group, LLP | 35,302 | $62.0K |
| Simplex Trading, LLC | 35,673 | $62.0K |
| Norges Bank | 27,700 | $48.5K |
| XTX Topco Ltd | 26,546 | $46.0K |
| Group One Trading, L.P. | 16,950 | $30.0K |
| Marshall Wace, LLP | 13,099 | $23.0K |
| Federated Hermes, Inc. | 152 | – |